| Literature DB >> 32495673 |
Xiao Liu1,2, Yuwei Wang3, Zhongxue Fu1.
Abstract
OBJECTIVE: To investigate the impact of enhanced recovery after surgery (ERAS) on the postoperative neutrophil-lymphocyte ratio (NLR) in patients with colorectal cancer.Entities:
Keywords: Enhanced recovery after surgery; colorectal cancer; complication; inflammation; neutrophil–lymphocyte ratio; perioperative management
Mesh:
Year: 2020 PMID: 32495673 PMCID: PMC7273621 DOI: 10.1177/0300060520925941
Source DB: PubMed Journal: J Int Med Res ISSN: 0300-0605 Impact factor: 1.671
Comparison of intervention measures during the perioperative period between the ERAS and control groups.
| Traditional treatment | ERAS | ||
|---|---|---|---|
| Preoperative preparation | 1: Propaganda and education | Before surgery, patients were provided with treatment-related information regarding the surgical procedure, risk of surgery, and corresponding treatment measures | |
| 2: Gastrointestinal preparation | Fasting for 8–12 hours before operation; drinking forbidden 2 hours before surgery; routine mechanical enema before surgery; routine indwelling gastric tube and urinary catheter | Polyethylene glycol 4000 (Fusong; English name: Macrogol 4000 powder; Bofu-Epson, Tianjin, Pharmaceutical Co., Ltd., Tianjin, China), 200 g dissolved in 2000 mL of warm water administered orally 1 day before surgery (provided by the hospital); 500 mL 10% glucose solution administered orally 2 hours before surgery; gastric and urethral tubes not placed before surgery | |
| Intraoperative operation | 1: Body temperature management | No specific temperature-control measures | Maintain normal body temperature (underarm 36.0–37.0°C) by, e.g., regulating room temperature, infusion heating device |
| 2: Liquid management | No specific requirements | Esophageal Doppler ultrasound used to monitor effects of fluid intake on cardiac output, and to determine fluid perfusion during the procedure | |
| Postoperative intervention | 1: Analgesia | Intramuscular analgesics given when the patient reported severe pain | Analgesia administered via continuous epidural analgesia, intravenous self-controlled analgesia pump, non-steroidal anti-inflammatory drugs, and multimodal analgesia |
| 2: Catheter indwelling | After surgery, the indwelling catheter was left in place for 4–7 days; gastric tube removed after first anal exhaust | Catheter left for < 3 days after low-rectal surgery, and colon indwelling catheter left for < 1 day. No nasogastric tube left after surgery | |
| 3: Early enteral nutrition | Stomach tube withdrawn after venting; soft food, gradually become semi-liquid, followed by normal diet | Eating encouraged 4 hours after surgery if patient’s condition stable, with slow transition to fluid diet based on gastrointestinal tolerance | |
| 4: Early activities | Postoperative activities taken on a voluntary basis | Patient encouraged to get out of bed within 24 hours after surgery, under the guidance of the nursing staff, if the patient can withstand it | |
ERAS, enhanced recovery after surgery.
Comparison of preoperative clinical data between the two groups.
| Parameter | ERAS | Traditional treatment | Statistics | ||
|---|---|---|---|---|---|
| Age, years | 68.49 ± 11.17 | 65.95 ± 10.08 | 0.087 | ||
| Sex, male/female | 57/43 | 48/52 | χ2 = 1.624 | 0.257 | |
| BMI, kg/m2 | 21.96 ± 2.21 | 22.29 ± 2.39 | 0.313 | ||
| ASA score, n | χ2 = 0.59 | 0.744 | |||
| I | 33 | 28 | |||
| II | 38 | 41 | |||
| III | 29 | 31 | |||
| Tumor location, n | χ2 = 0.394 | 0.821 | |||
| Rectal cancer | 50 | 48 | |||
| Left colon cancer | 31 | 35 | |||
| Right colon cancer | 19 | 17 | |||
| TNM stage (number of cases) | χ2 = 0.375 | 0.829 | |||
| I | 30 | 34 | |||
| II | 44 | 41 | |||
| III | 26 | 25 | |||
Data presented as mean ± standard deviation or n. ERAS, enhanced recovery after surgery; BMI, body mass index.
Comparison of postoperative complications between the two groups.
| Anastomotic fistula | Lung infection | Deep vein thrombosis | Heart and lung dysfunction | Intestinal obstruction | Incision infection | Urinary tract infection | Gastrointestinal bleeding | |
|---|---|---|---|---|---|---|---|---|
| ERAS | 0 | 1 | 0 | 4 | 2 | 1 | 2 | 0 |
| Traditional treatment | 6 | 8 | 3 | 14 | 4 | 2 | 10 | 1 |
| χ2 | 6.186 | 5.701 | 3.046 | 6.105 | 0.687 | 0.338 | 5.674 | 1.005 |
| 0.029 | 0.035 | 0.081 | 0.024 | 0.407 | 0.561 | 0.033 | 0.316 |
ERAS, enhanced recovery after surgery.
Comparison of postoperative data between the two groups.
| First exhaust time (days) | First defecation time (days) | Hospital stay (days) | Hospitalization expenses (10,000 ¥) | |
|---|---|---|---|---|
| Traditional treatment | 3.83 ± 0.66 | 5.09 ± 0.53 | 12.13 ± 2.58 | 5.08 ± 0.66 |
| ERAS | 2.95 ± 0.54 | 4.13 ± 0.55 | 8.96 ± 0.59 | 4.00 ± 0.56 |
| 10.893 | 11.78 | 12.125 | 14.073 | |
| <0.01 | <0.01 | <0.01 | <0.01 |
Comparisons of neutrophil–lymphocyte ratio, total protein, and albumin during the perioperative period between the two groups.
| Parameter | Traditional treatment | ERAS | ||
|---|---|---|---|---|
| Preoperative NLR | 2.96 ± 0.98 | 3.03 ± 0.92 | −0.559 | 0.577 |
| Postoperative NLR | 3.71 ± 0.68 | 3.22 ± 0.85 | 4.666 | <0.01 |
| Preoperative TP (g/L) | 71.40 ± 5.36 | 70.09 ± 6.12 | 1.565 | 0.121 |
| Preoperative ALB (g/L) | 45.78 ± 3.67 | 44.94 ± 3.80 | 1.556 | 0.123 |
| Postoperative TP (g/L) | 52.92 ± 1.73 | 57.82 ± 2.27 | −17.145 | <0.01 |
| Postoperative ALB (g/L) | 32.83 ± 1.69 | 37.07 ± 1.46 | −18.33 | <0.01 |
ERAS, enhanced recovery after surgery; NLR, neutrophil–lymphocyte ratio; TP, total protein; ALB, albumin.